Center for Addiction Medicine


Publication Alert: New Subgroup Analysis for the EAGLES Trial

Psychiatric Services recently published results from a post hoc analysis of CAM Director Dr. Eden Evins’s EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) trial showing the efficacy of Varenicline in smokers with schizophrenia. The analysis found that Varenicline was more effective than placebo, Bupropion, or nicotine patch for smokers with schizophrenia. Additionally the odds…MORE

Dr. John Kelly Discusses Addiction and Brain Chemistry in Variety Magazine’s Recovery Issue

The Variety Magazine Recovery Issue, in its explanation of current addiction research, featured CAM Associate Director Dr. John Kelly to discuss how early substance use may impact brain chemistry development. The article, entitled “The Science of Addiction: How Substance Abuse Changes Brain Chemistry,” interviews addiction medicine researchers across the country to explore how biological, social…MORE

CAM Cannabis Intoxication Research Featured on Advances in Motion

Advances in Motion currently features the promising results of the Center for Addiction Medicine’s fNIRS study, with contributions from CAM Director Dr. Eden Evins and Director of Neuroscience Dr. Jodi Gilman. The article details important findings and future steps in assessing portable neuroimaging’s capacity to detect cannabis intoxication. To read the article, please visit:

CAM Poster Wins Two Awards at MGH Clinical Research Day

Co-first authors Rachel Plummer, Kelsey Lowman and Dr. Melissa Maravic received the Clinical and Outcome Research Award for their poster, “Behavioral Changes in Smokers from the PCORI Pragmatic Trial ‘Integrated Smoking Cessation Treatment for Smokers with Serious Mental Illness,’” at the 2019 Clinical Research Day. The poster also won a First Prize award from the…MORE

U.S. Surgeon General Issues Advisory On Impact of Marijuana Use

To emphasize the health risks of marijuana use in adolescence and during pregnancy, the U.S. Surgeon General recently issued a general warning explaining the drug’s harmful effects on the developing brain. The Surgeon General cited increased access to and potency of marijuana, along with misinformation about its safety, as contributing factors in the drug’s increasing…MORE

CAM Competes in Shatterproof 5K

In recognition of September as National Recovery Month, CAM participated in a month-long celebration with a series of events open to staff, patients, families and the community, including Narcan training sessions and educational forums. This month of awareness culminated in the Shatterproof 5K run/walk on Sept. 22., which raised money to support those who have…MORE

CAM Intern Receives Multiple Harvard Fellowship Awards

The Harvard University Mind, Brain, Behavior Interfaculty Initiative recently selected Audrey Mustoe, a CAM intern and undergraduate student at Harvard University, as a Mary Gordon Roberts 2019 Summer Research Fellow. The award is given to several Harvard University undergraduates each year to support research that will contribute to students’ senior honors theses. Audrey also recently…MORE

Massachusetts Prevention Alliance (MAPA) Invites Dr. Eden Evins to Present Marijuana-Psychosis Link Research

A. Eden Evins, M.D., M.P.H., Ceneter for Addiction Medicine Director, Principal Investigator, Associate Professor, Harvard Medical School

Dr. Eden Evins, Founding Director of MGH’s Center for Addiction Medicine and Harvard Medical School Professor of Psychiatry, will present recent findings on the interaction between marijuana use and psychosis at an upcoming MAPA conference. The luncheon event will focus on advances in marijuana research within the past five years and how recent findings impact…MORE

CAM Neuropsych Director Wins Annual Best Paper Award

Randi Schuster, Ph.D. received the fifth annual Best Paper distinction in The Journal of Clinical Psychiatry from the American Society of Clinical Psychopharmacology (ASCP) for her report on the effects of cannabis abstinence in adolescents and young adults. The paper, entitled “One Month of Cannabis Abstinence in Adolescents and Young Adults is Associated with Improved Memory,” found…MORE

Randi Schuster Named 2019 Claflin Distinguished Scholar

Randi Schuster

In celebration and recognition of female faculty with child-rearing responsibilities, the MGH Executive Research Committee (ECOR) selected Randi Schuster, Ph.D., as a 2019 Claflin Distinguished Scholar, making her the first recipient of the distinction in the Center’s history. The award will fund Dr. Schuster’s pilot study “Effect of Six-Months of Cannabis Abstinence on Cognition, Academic, and…MORE